Anzeige
+++>>> Gediegen Kupfer im Bohrkern: Kupfer auf Allzeithoch – und in diesem Bohrkern glänzt das Metall in reiner Form <<<+++
PortfolioPlus
Portfolio-Tracker – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
EQS-News

DEMETRA ANNOUNCES A STRATEGIC COLLABORATION WITH MASMEC BIOMED 22.07.2026, 09:05 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Demetra Group / Key word(s): Miscellaneous
DEMETRA ANNOUNCES A STRATEGIC COLLABORATION WITH MASMEC BIOMED

22.07.2026 / 09:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


From leadership in vertebral surgery technologies to the creation of a European innovation ecosystem built on AI, data, navigation, and robotics

MILAN, July 22, 2026 /PRNewswire/ -- Demetra Holding announces a strategic collaboration with Masmec Biomed, an Italian company specialized in the development of advanced surgical navigation systems, AI, and high-complexity medical technologies.

Michele Perrino, CEO, Demetra

The collaboration stems from the complementary strengths of the two organizations. Demetra brings consolidated expertise in the orthopedic, spine and neuro sectors, an international presence, and a deep understanding of market needs. Masmec contributes advanced competencies in biomedical engineering, surgical navigation, artificial intelligence, and technologies derived from highly innovative industries, laying the foundation for accelerating the adoption of increasingly sophisticated solutions for surgeons, healthcare facilities, and patients.

"Demetra's story began in operating rooms, alongside surgeons. That is still where we look to understand the future. A new generation of technologies emerging-technologies will make surgery more precise, more predictive, and increasingly personalized. Such a transformation requires a new industrial model, capable of connecting clinical expertise, artificial intelligence, navigation, robotics, and data. Our ambition is not simply to participate in this change. but to help build it, reflecting a transformation that is set to redefine the MedTech sector," said Michele Perrino, CEO of Demetra Holding.

The collaboration between Demetra and Masmec reinforces a conviction that the future will not be driven solely by new implants, new materials, or new surgical techniques, but by the ability to integrate clinical knowledge, data, software, AI, and advanced technologies into an ecosystem capable of improving every phase of the care pathway.

In recent years, Demetra has strengthened its position in the orthopedic, neuro and spine sectors, developing an increasingly comprehensive portfolio and expanding its international footprint. Today, the Group is looking beyond the traditional boundaries of medical devices, investing in the technologies that are redefining the very concept of surgery.

According to market analyses, applications based on surgical navigation and artificial intelligence represent one of the fastest-growing segments in the entire sector, with significant potential for adoption across multiple surgical disciplines and substantial room for evolution in the coming years.

In this context, Demetra aims to establish itself as a European platform for clinical and technological innovation, capable of identifying, connecting, and enhancing the best expertise in the sector while accelerating the adoption of advanced solutions.

"Being chosen by Demetra is a great pride for us and confirms the value of the work we have carried out over the years," said Daniela Vinci, CEO of Masmec. "We share the same vision and ambition: increasingly personalized care enabled by technology that ensures accurate diagnosis, minimally invasive procedures, and an approach centered on patient respect and healthcare system sustainability. Demetra offers the solidity and authority of a well-established market player, while Masmec brings continuous innovation and a relentless pursuit of quality. This is where we find the space to continue innovating, with a partner capable of giving scale and perspective to our work."

"The most relevant companies of the next decade will not be those that simply produce better technologies, but those capable of creating ecosystems where innovation, knowledge, and expertise work together to generate value. This is the future we are building: not a single product, but the creation of a new generation of solutions for surgery," concluded Michele Perrino, CEO of Demetra Holding.

Through this collaboration, Demetra continues its evolution from a leader in the spine sector to a promoter of a new paradigm for European MedTech in which surgery, data, artificial intelligence, and innovation converge to build the next generation of care.

Demetra Logo

Masmec Logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/demetra-announces-a-strategic-collaboration-with-masmec-biomed-302830890.html

rt.gif?NewsItemId=EN08958&Transmission_Id=202607220300PR_NEWS_EURO_ND__EN08958&DateId=20260722


22.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2369668  22.07.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer